Email this article Systemic amyloidosis in a patient with acute heart failure
- Authors: Shekhovtsova E.V.1, Lukashik E.V.1, Bogochanova O.A.2, Kolonutov M.S.2, Kudinova M.A.2, Reznik E.V.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- N.I. Demikhov City Clinical Hospital, Moscow Healthcare Department
- Issue: Vol 18, No 2 (2024)
- Pages: 30-37
- Section: CASE REPORT
- Published: 01.09.2024
- URL: https://klinitsist.abvpress.ru/Klin/article/view/600
- DOI: https://doi.org/10.17650/1818-8338-2024-18-2-K698
- ID: 600
Cite item
Full Text
Abstract
Aim. To describe a clinical case of transthyretin amyloidosis, the first manifestation of which was an episode of acute heart failure.
Materials and methods. Patient V., 58 years old, was taken to the intensive care unit for patients with myocardial infarction V.P. Demikhov State Clinical Hospital with a preliminary diagnosis: acute coronary syndrome without ST segment elevation, pulmonary edema. It is known from the anamnesis that the patient was disturbed for 3 months by a pronounced dry cough, hoarseness of voice, weakness with minor physical exertion.
Results. The complexity of the diagnosis of postmortem diagnosis of systemic amyloidosis was explained by the absence of any clinical manifestations that made it possible to suspect a deadly disease before hospitalization for pulmonary edema. This clinical case demonstrates the rapid development of symptoms of systemic amyloidosis. From the moment of the first symptoms (persistent dry cough, hoarseness of voice) to death as a result of heart failure, about 3 months have passed. The addition of peripheral polyneuropathy to the clinical picture made it possible to suspect a systemic disease.
Conclusion. This clinical case proves the relevance and importance of timely diagnosis of amyloidosis, as well as the need to raise awareness of doctors of various specialties about this disease.
About the authors
E. V. Shekhovtsova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Author for correspondence.
Email: ev.shekhovtsova@yandex.ru
ORCID iD: 0009-0002-2262-4116
Elizaveta Vasilyevna Shekhovtsova - Department of Propaedeutics of Internal Diseases and Radiation Diagnostics of the Faculty of Medicine.
1 Ostrovityanova St., Moscow 117997
Russian FederationE. V. Lukashik
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
ORCID iD: 0009-0000-8611-169X
Department of Propaedeutics of Internal Diseases and Radiation Diagnostics of the Faculty of Medicine.
1 Ostrovityanova St., Moscow 117997
Russian FederationO. A. Bogochanova
N.I. Demikhov City Clinical Hospital, Moscow Healthcare Department
ORCID iD: 0000-0001-9202-2917
4 Shkuleva St., Moscow 109263
Russian FederationM. S. Kolonutov
N.I. Demikhov City Clinical Hospital, Moscow Healthcare Department
ORCID iD: 0009-0009-6512-3400
4 Shkuleva St., Moscow 109263
Russian FederationM. A. Kudinova
N.I. Demikhov City Clinical Hospital, Moscow Healthcare Department
ORCID iD: 0000-0002-3223-8457
4 Shkuleva St., Moscow 109263
Russian FederationE. V. Reznik
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
ORCID iD: 0000-0001-7479-418X
Department of Propaedeutics of Internal Diseases and Radiation Diagnostics of the Faculty of Medicine.
1 Ostrovityanova St., Moscow 117997
Russian FederationReferences
- Rameev V.V., Myasnikov R.P., Vinogradov P.P. et al. Systemic ATTR-amyloidosis, a rare form of internal organ damage. Racional`naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology 2019;15(3):349–58. doi: 10.20996/1819-6446-2019-15-3-349-358
- Tereshchenko S.N., Nasonova S.N., Zhirov I.V. et al. Federal State Budgetary Institution “National Medical Research Center of Cardiology”. Moscow: National Medical Research Center of Cardiology of the Ministry of Health of the Russia, 2021.
- Reznik E.V., Nguyen T.L., Stepanova E.A. et al. Cardiac Amyloidosis: Internist and Cardiologist Insight. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine 2020; 10(6): 430–57. (In Russ.). doi: 10.20514/2226-6704-2020-10-6-430-457
- Adyan T.A., Polyakov A.V. Hereditary transthyretin amyloidosis. Nervno-myshechnye bolezni = Neuromuscular Diseases 2019; 9(4):12–25. (In Russ.). doi: 10.17650/2222-8721-2019-9-4-12-25
- Tereshchenko S.N., Zhirov I.V., Moiseeva O.M. et al. Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis). Terapevticheskii arkhiv = Therapeutic Archive 2022;94(4):584–95. (In Russ.). doi: 10.26442/00403660.2022.04.201465
- Papingiotis G., Basmpana L., Farmakis D. Cardiac amyloidosis: epidemiology, diagnosis and therapy. Available at: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-19/cardiac-amyloidosis-epidemiology-diagnosis-andtherapy
- Khyshova V.A., Rekhtina I.G., Firsova M.V., Mendeleeva L.P. Difficulties in diagnosis primary AL-amyloidosis. Onkogematologiya = Oncohematology 2021;16(3):74–82. (In Russ.). doi: 10.17650/1818-8346-2021-16-3-74-82
- Reznik E.V., Nguyen T.L., Borisovskaya S.V. et al. A Clinical Case of the Hereditary Transthyretin Amyloidosis. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine 2021;11(3): 229–40. (In Russ.). doi: 10.20514/2226-6704-2021-11-3-229-240
- Rameeva A.S., Rameev V.V., Bobkova I.N. et al. Leading Factors of Progression in Patients with Cardiac Amyloidosis. Racional`naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology 2022;18(2):143–52. (In Russ.). doi: 10.20996/1819-6446-2022-04-02
- Nomura T., Ueda M., Tasaki M. et al. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis. Orphanet J Rare Dis 2019;14(1):116. doi: 10.1186/s13023-019-1100-y
Supplementary files
